clinical-trial-recruitment
(12)
Vi and the expensive art of showing up
A $249 running coach became an AI business for health enterprises. Vi’s wager: the valuable prediction is the one that gets someone to act.
The Agency That Bought the Missing Pieces
Spectrum Science began with a narrow conviction: complicated medicine deserves clear storytelling. Three decades and a run of acquisitions later, the more interesting product is the machinery behind the message.
The Small Agency That Learned to Be Everywhere
For forty years, MCS Health has sold a peculiar advantage: the attention of a specialist shop with the reach of a network. Its 2025 reset shows what happens when a boutique decides scale should be borrowed, not owned.
The Agency That Learned to Buy Its Way Out of a Bad Year
Real Chemistry began as one consultant with a healthcare Rolodex. A bruising 2008 taught it a stranger lesson: when clients need several kinds of expertise at once, the agency itself has to become a portfolio.
ENTENTE Network and the Last Mile of Science
The bottleneck in biotechnology is not always discovery. Sometimes it is the sentence that makes an investor, patient, regulator, or reporter understand why the discovery matters. ENTENTE built a consultancy - and a set of intelligence tools - for that last mile.
Argot Partners and the Fine Art of Making Biology Make Sense
A drug can work in the lab and still fail in the telling. Argot Partners built a business around the awkward, consequential space between scientific truth and public understanding.
Russo Partners Takes Medicine to Radio Row
A 24-person healthcare communications boutique found an unlikely door into public health: the football postseason. Its real product is not publicity, but translation under pressure.
When Public Relations Became Too Small for LifeSci
The agency began with a narrow label and kept adding jobs until the label broke. Its answer is a useful lesson in how to sell difficult science: put the people who understand it beside the people who know how to make others care.
The Six-Week Reversal: How Cullari Communications Global Turns Trust Into Infrastructure
The Hershey consultancy does not sell attention for its own sake. It builds coalitions around the people whose trust a health company cannot manufacture - and measures what happens next.
Merryman Communications and the art of the next click
A patient story is only the beginning. The healthcare agency now called M+ builds the route from attention to action - and changes the route when the numbers tell it to.
Reveal HealthTech
Reveal HealthTech is a New York-based AI transformation partner for U.S. healthcare and life sciences organizations. Founded in 2023 and incubated by W Health Ventures and 2070 Health, the company pairs clinical expertise with engineering and design to turn AI concepts into deployed products for hospitals, pharma, and digital health innovators. Its flagship products include BioCanvas for clinical trial recruitment, Prism AI for workflow automation, and CareIQ for care coordination. Reveal raised a $7.2M Series A led by Leo Capital in September 2025 and runs teams across the U.S. and Bengaluru, India.
Dyania Health
Dyania Health builds Synapsis AI, a medically trained large language model that reads unstructured electronic medical records - physician notes, pathology reports, imaging notes - and answers complex clinical questions with roughly 95% accuracy in under a second per record. Deployed inside health systems' own firewalls, the platform automates clinical trial pre-screening, chart abstraction, observational studies, and registry reporting, turning weeks of manual nurse and physician chart review into minutes. Founded in 2020 by former Morgan Stanley dealmaker Eirini Schlosser and headquartered in Jersey City with a team in Athens, the company raised a $10M Series A in 2024 and counts Cleveland Clinic among its earliest enterprise partners.